EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of Combined MET/HGF Expression With the Colorectal Cancer Immune Microenvironment: An Integrated Immunohistochemical and Multi‐Database Analysis

Shuai Luo iD, Hongwei Guo, Xiangli Li iD, Yiyan Long iD, Zepeng Xin, Yanli Cheng

Cancer Medicine · 2026

DOI: 10.1002/cam4.72214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Shuai Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Hospital of Tsinghua University, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-met, Tumor Microenvironment, Colorectal Neoplasms, Hepatocyte Growth Factor. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Key Laboratory of Helicobacter pylori Infection and Upper Gastrointestinal Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To validate c‐MET protein expression in colorectal cancer (CRC) and assess whether joint MET and hepatocyte growth factor (HGF) transcript expression provides descriptive information on tumor microenvironment features beyond MET alone. Methods c‐MET protein expression was evaluated by immunohistochemistry in 51 paired CRC and adjacent tissues. The Cancer Genome Atlas (TCGA) and TNMplot datasets assessed MET mRNA expression and clinicopathological associations; Kaplan–Meier Plotter evaluated unadjusted survival; and TIMER (Tumor Immune Estimation Resource) examined purity‐adjusted immune correlations. In TCGA colon adenocarcinoma (COAD) and rectal adenocarcinoma (READ) cohorts, samples were divided using cohort‐specific median MET and HGF expression. ESTIMATE (Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data) and CIBERSORT (Cell‐type Identification by Estimating Relative Subsets of RNA Transcripts) compared inferred tumor purity, immune/stromal scores, and immune‐cell composition. These computational estimates were not experimentally validated in this study.

Results

MET mRNA was elevated in CRC datasets, and c‐MET protein H‐scores were higher in CRC than in paired adjacent tissues. MET expression was not associated with the tested clinicopathological variables. High MET expression was associated with shorter overall and relapse‐free survival in unadjusted analyzes. In both cohorts, the MET‐high/HGF‐low group generally showed higher estimated tumor purity and lower immune and stromal scores, whereas the MET‐low/HGF‐high group showed the converse pattern. Individual immune‐cell subset differences were cohort dependent.

Conclusion

MET mRNA and c‐MET protein are elevated in CRC. Joint MET/HGF expression may complement MET‐only analysis by retaining discordant patterns associated with inferred tumor‐cell and immune/stromal composition. These retrospective, algorithm‐derived findings do not establish independent prognostic value, HGF/c‐MET pathway activation or causality, or a basis for clinical patient stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-metTumor MicroenvironmentColorectal NeoplasmsHepatocyte Growth FactorHumansImmunohistochemistryFemaleMalePrognosisBiomarkers, TumorGene Expression Regulation, NeoplasticMiddle AgedAgedKaplan-Meier EstimateAdenocarcinoma

Stichwörter der Autor:innen

METcolorectal cancerc‐METhepatocyte growth factorimmunohistochemistrytumor immune microenvironment

Substanzen

Proto-Oncogene Proteins c-metHepatocyte Growth FactorMET protein, humanHGF protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • The First Hospital of Tsinghua University, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China.

ORCID-Profile: Shuai Luo, Xiangli Li, Yiyan Long

Förderung

  • Beijing Key Laboratory of Helicobacter pylori Infection and Upper Gastrointestinal Diseases

Zitieren

APA

Luo, S., Guo, H., Li, X., Long, Y., Xin, Z., & Cheng, Y. (2026). Association of Combined MET/HGF Expression With the Colorectal Cancer Immune Microenvironment: An Integrated Immunohistochemical and Multi‐Database Analysis. Cancer Medicine. https://doi.org/10.1002/cam4.72214

Vancouver

Luo S, Guo H, Li X, Long Y, Xin Z, Cheng Y. Association of Combined MET/HGF Expression With the Colorectal Cancer Immune Microenvironment: An Integrated Immunohistochemical and Multi‐Database Analysis. Cancer Medicine. 2026. doi:10.1002/cam4.72214

BibTeX
@article{Luo2026,
  author = {Luo, Shuai and Guo, Hongwei and Li, Xiangli and Long, Yiyan and Xin, Zepeng and Cheng, Yanli},
  title = {Association of Combined MET/HGF Expression With the Colorectal Cancer Immune Microenvironment: An Integrated Immunohistochemical and Multi‐Database Analysis},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.72214}
}
Kostenlos starten →